Laura Lane joins Black Swan

pharmafile | December 6, 2010 | Appointment | Sales and Marketing |  Black Swan Analysis, Laura Lane, appointment, sales and marketing 

Black Swan Analysis has appointed Dr Laura Lane to its Analysis and Forecasting team.

Laura brings with her a strong scientific background following the completion of her PhD at the University of Cambridge.

Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

white_and_ford

Abbott CEO to step down after 21 years

After more than two decades at the head of the company, it has emerged that …

The Gateway to Local Adoption Series

Latest content